ATA41287A - Verfahren zur herstellung von 4-methoxy-2'-(2(1-methyl-2-piperidyl)aethyl)benzanilid - Google Patents

Verfahren zur herstellung von 4-methoxy-2'-(2(1-methyl-2-piperidyl)aethyl)benzanilid

Info

Publication number
ATA41287A
ATA41287A AT0041287A AT41287A ATA41287A AT A41287 A ATA41287 A AT A41287A AT 0041287 A AT0041287 A AT 0041287A AT 41287 A AT41287 A AT 41287A AT A41287 A ATA41287 A AT A41287A
Authority
AT
Austria
Prior art keywords
aethyl
benzanilide
piperidyl
methoxy
methyl
Prior art date
Application number
AT0041287A
Other languages
English (en)
Other versions
AT394716B (de
Original Assignee
Bristol Myers Squibb Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bristol Myers Squibb Co filed Critical Bristol Myers Squibb Co
Publication of ATA41287A publication Critical patent/ATA41287A/de
Application granted granted Critical
Publication of AT394716B publication Critical patent/AT394716B/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
    • C07D211/10—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with radicals containing only carbon and hydrogen atoms attached to ring carbon atoms
    • C07D211/14—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with radicals containing only carbon and hydrogen atoms attached to ring carbon atoms with hydrocarbon or substituted hydrocarbon radicals attached to the ring nitrogen atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
    • C07D211/18—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D211/26—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by nitrogen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/02—Preparation by ring-closure or hydrogenation

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Hydrogenated Pyridines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
AT0041287A 1986-02-25 1987-02-25 Verfahren zur herstellung von 4-methoxy-2'-(2(1-methyl-2-piperidyl)aethyl)benzanilid AT394716B (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/833,295 US4675409A (en) 1986-02-25 1986-02-25 Process for the preparation of encainide

Publications (2)

Publication Number Publication Date
ATA41287A true ATA41287A (de) 1991-11-15
AT394716B AT394716B (de) 1992-06-10

Family

ID=25264016

Family Applications (1)

Application Number Title Priority Date Filing Date
AT0041287A AT394716B (de) 1986-02-25 1987-02-25 Verfahren zur herstellung von 4-methoxy-2'-(2(1-methyl-2-piperidyl)aethyl)benzanilid

Country Status (23)

Country Link
US (1) US4675409A (de)
JP (1) JPS62240659A (de)
KR (1) KR900001203B1 (de)
AT (1) AT394716B (de)
AU (1) AU597939B2 (de)
BE (1) BE1000112A5 (de)
CA (1) CA1291483C (de)
CH (1) CH671223A5 (de)
DE (1) DE3705664A1 (de)
DK (1) DK94487A (de)
ES (2) ES2002637A6 (de)
FI (1) FI85853C (de)
FR (1) FR2595353B1 (de)
GB (1) GB2187189B (de)
GR (1) GR870281B (de)
HU (1) HU196960B (de)
IL (1) IL81657A0 (de)
IT (1) IT1203501B (de)
LU (1) LU86785A1 (de)
NL (1) NL8700452A (de)
PT (1) PT84348B (de)
SE (1) SE464301B (de)
ZA (1) ZA871334B (de)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4800226A (en) * 1986-02-25 1989-01-24 Bristol-Myers Company Process intermediate for the preparation of encainide
WO2007111705A2 (en) * 2005-11-17 2007-10-04 Novartis Ag Benzeneszkfibate salts and their use as intermediates for the synthesis of 2-[2-(1-alkyl-2-piperidyl)ethyl] cinnamanilides

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3931195A (en) * 1971-03-03 1976-01-06 Mead Johnson & Company Substituted piperidines
US4000143A (en) * 1971-03-03 1976-12-28 Mead Johnson & Company Substituted piperidines
US4064254A (en) * 1971-03-03 1977-12-20 Mead Johnson & Company Substituted piperidines therapeutic process and compositions
CA961038A (en) * 1971-03-03 1975-01-14 Joseph L. Minielli Substituted piperidines
US4394507A (en) * 1981-12-14 1983-07-19 Mead Johnson & Company Process for production of encainide

Also Published As

Publication number Publication date
FI870767A (fi) 1987-08-26
CA1291483C (en) 1991-10-29
JPS62240659A (ja) 1987-10-21
FI870767A0 (fi) 1987-02-23
BE1000112A5 (fr) 1988-03-29
SE8700776L (sv) 1987-08-26
ZA871334B (en) 1987-10-28
DK94487D0 (da) 1987-02-24
AT394716B (de) 1992-06-10
NL8700452A (nl) 1987-09-16
SE464301B (sv) 1991-04-08
CH671223A5 (de) 1989-08-15
AU597939B2 (en) 1990-06-14
AU6924687A (en) 1987-08-27
GR870281B (en) 1987-06-30
FR2595353A1 (fr) 1987-09-11
ES2002637A6 (es) 1988-09-01
KR870007887A (ko) 1987-09-22
HUT43563A (en) 1987-11-30
GB8703882D0 (en) 1987-03-25
SE8700776D0 (sv) 1987-02-24
FR2595353B1 (fr) 1990-11-30
US4675409A (en) 1987-06-23
DK94487A (da) 1987-08-26
HU196960B (en) 1989-02-28
IT8719475A0 (it) 1987-02-24
ES2007062A6 (es) 1989-06-01
GB2187189A (en) 1987-09-03
IT1203501B (it) 1989-02-15
KR900001203B1 (ko) 1990-02-28
FI85853C (fi) 1992-06-10
GB2187189B (en) 1990-01-10
DE3705664C2 (de) 1989-09-28
LU86785A1 (fr) 1987-09-15
PT84348A (en) 1987-03-01
DE3705664A1 (de) 1987-08-27
IL81657A0 (en) 1987-09-16
FI85853B (fi) 1992-02-28
PT84348B (pt) 1989-09-14

Similar Documents

Publication Publication Date Title
DE3762745D1 (de) Verfahren zur herstellung von 2-chlor-5-chlormethylthiazol.
DE3763558D1 (de) Verfahren zur herstellung von 2-chlor-5-chlormethylpyridin.
DE3762855D1 (de) Verfahren zur herstellung von hydroxyalkylaminen und hydroxyalkylpiperazinen.
DE3684922D1 (de) Verfahren zur herstellung von 2-phenylbenzotriazolen und 2-phenylbenzotriazol-n-oxyden.
DE3780527D1 (de) Verfahren zur herstellung von 5'-guanyl-saeure.
DE3674379D1 (de) Verfahren zur herstellung von perfluorcarbonsaeuren.
DE3770224D1 (de) Verfahren zur herstellung von hypofluoriten und bis-hypofluoriten.
ATA53886A (de) Verfahren zur herstellung von chlordioxid
DE3766910D1 (de) Verfahren zur herstellung von dihydrocyclocitral.
DE3769076D1 (de) Verfahren zur herstellung von fluorbenzaldehyden.
ATA144987A (de) Verfahren zur herstellung von neuen anthracyclinglykosiden
DE3776980D1 (de) Verfahren zur herstellung von feinstrukturen.
DE3769263D1 (de) Verfahren zur herstellung von bromfluoroethylhypofluorit.
ATA95587A (de) Verfahren zur herstellung von glucosylmoranolin
ATA41287A (de) Verfahren zur herstellung von 4-methoxy-2'-(2(1-methyl-2-piperidyl)aethyl)benzanilid
ATA247687A (de) Verfahren zur herstellung von 5-aryliden- und -alkylidensubstituierten hydantoinen
DE3767948D1 (de) Verfahren zur herstellung von tertiaeren alkylphosphanen.
DE3775094D1 (de) Verfahren zur herstellung von 4'-hydroxybiphenyl-4-carbonsaeure.
ATA121387A (de) Verfahren zur herstellung von moranolinderivaten
DE3766396D1 (de) Verfahren zur herstellung von trichlormelamin.
DE3766013D1 (de) Verfahren zur herstellung von n-aminohexamethylenimin.
AT378182B (de) Verfahren zur herstellung von 4-methoxy-2'-(2-(1-methyl-2-piperidyl)aethyl)benzanilid
AT389510B (de) Verfahren zur herstellung von 2-guanidinothiazol- derivaten
AT397651B (de) Verfahren zur herstellung von bromfluormethan
DE3762856D1 (de) Verfahren zur herstellung von hydroxybenzaldoxim-o-ethern.

Legal Events

Date Code Title Description
ELJ Ceased due to non-payment of the annual fee
REN Ceased due to non-payment of the annual fee